Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial

Tolaney et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69daaff44a1e15904c835b11 — DOI: https://doi.org/10.1200/jco.20.03398

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study· 2006 · 654 citations
2. Evaluation of the alopecia patient assessment (APA) questionnaire in women with breast cancer and alopecia· 2013 · 2 citations
3. Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond· 2020 · 16 citations
4. Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer· 2005 · 5,089 citations
5. Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy· 2010 · 763 citations